» Authors » Jeanet Serafin-Lopez

Jeanet Serafin-Lopez

Explore the profile of Jeanet Serafin-Lopez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 264
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Castillo-Cruz J, Palacios-Barreto S, Mosso-Pani M, Pani A, Serna Perez A, Rodriguez-Tovar A, et al.
Microb Pathog . 2025 Mar; :107479. PMID: 40089194
In recent years, Candida glabrata (C. glabrata) has emerged as a pathogen responsible for systemic mortal infections. C. glabrata invades nonphagocytic cells, but the mechanisms involved in its internalization and...
2.
Pacheco-Garcia U, Varela-Lopez E, Serafin-Lopez J
Int J Mol Sci . 2024 Jul; 25(14). PMID: 39062904
Through widespread immunization against SARS-CoV-2 to or -infection, a substantial segment of the global population has acquired both humoral and cellular immunity, and there has been a notable reduction in...
3.
Peregrino E, Castaneda-Casimiro J, Vazquez-Flores L, Estrada-Parra S, Wong-Baeza C, Serafin-Lopez J, et al.
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892397
Pathogenic bacteria have several mechanisms to evade the host's immune response and achieve an efficient infection. Bacterial extracellular vesicles (EVs) are a relevant cellular communication mechanism, since they can interact...
4.
Pacheco-Garcia U, Serafin-Lopez J
Vaccines (Basel) . 2023 Mar; 11(3). PMID: 36992239
It has been 34 months since the beginning of the SARS-CoV-2 coronavirus pandemic, which causes the COVID-19 disease. In several countries, immunization has reached a proportion near what is required...
5.
Vazquez-Flores L, Castaneda-Casimiro J, Vallejo-Castillo L, Alvarez-Jimenez V, Peregrino E, Garcia-Martinez M, et al.
J Leukoc Biol . 2023 Mar; 113(6):588-603. PMID: 36987875
Tuberculosis remains one of the leading public health problems in the world. The mechanisms that lead to the activation of the immune response against Mycobacterium tuberculosis have been extensively studied,...
6.
Hernandez-Solis A, Guemes-Gonzalez A, Ruiz-Gomez X, Alvarez-Maldonado P, Castaneda-Casimiro J, Flores-Lopez A, et al.
Immunobiology . 2022 Oct; 227(6):152288. PMID: 36209721
The clinical presentation of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranges between mild respiratory symptoms and a severe disease that shares...
7.
Ruiz-Sanchez B, Castaneda-Casimiro J, Cabrera-Rivera G, Brito-Arriola O, Cruz-Zarate D, Garcia-Paredes V, et al.
Microbiol Immunol . 2022 Jul; 66(10):477-490. PMID: 35856253
Most individuals infected with Mycobacterium tuberculosis (Mtb) have latent tuberculosis (TB), which can be diagnosed with tests (such as the QuantiFERON-TB Gold test [QFT]) that detect the production of IFN-γ...
8.
Soria-Castro R, Chavez-Blanco A, Garcia-Perez B, Wong-Baeza I, Flores-Mejia R, Flores-Borja F, et al.
Sci Rep . 2020 Oct; 10(1):17802. PMID: 33082490
Valproic acid (VPA) is a drug commonly used for epileptic seizure control. Recently, it has been shown that VPA alters the activation of several immune cells, including Natural Killer (NK)...
9.
Blancas-Galicia L, Santos-Chavez E, Deswarte C, Mignac Q, Medina-Vera I, Leon-Lara X, et al.
J Clin Immunol . 2020 Feb; 40(3):475-493. PMID: 32040803
Purpose: Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by an inability of phagocytes to produce reactive oxygen species, impairing their killing of various bacteria and fungi. We summarize...
10.
Garcia-Martinez M, Vazquez-Flores L, Alvarez-Jimenez V, Castaneda-Casimiro J, Ibanez-Hernandez M, Enid Sanchez-Torres L, et al.
Int J Nanomedicine . 2019 Nov; 14:6707-6719. PMID: 31692512
Background: Tuberculosis is the leading cause of death by an infectious microorganism worldwide. Conventional treatment lasts at least six months and has adverse effects; therefore, it is important to find...